The global medical waste management market was valued at USD 41.3 billion in 2025 and is projected to grow from USD 44.6 billion in 2026 to USD 76.4 billion in 2033, at a CAGR of 8.0% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 31.0% in 2025. The market growth is primarily driven by the continuous expansion of healthcare infrastructure, increasing hospital admissions, surgical procedures, diagnostic testing, and pharmaceutical activities, all of which generate larger volumes of regulated medical waste. Additionally, ongoing advancements in medical technologies and healthcare services are driving the adoption of advanced diagnostic, surgical, and treatment solutions, further increasing the need for efficient medical waste management.
In addition, the growing incidence of diseases like cancer and other chronic disorders, along with an increasing elderly population and road accidents, is leading to a heightened demand for these advanced medical solutions. Consequently, the widespread availability of advanced medical solutions, combined with a growing patient population, is resulting in a significant volume of waste and byproducts.
The pharmaceutical industry is experiencing swift progress in the adoption of innovative manufacturing techniques for drugs and medical devices. In addition, the market's expansion is evident in the effective supply chain management of inventory, which is crucial to the daily operations of hospitals, clinics, and diagnostic centers. Consequently, this heightened activity contributes to increased generation of medical waste. To manage these by-products and residues, there is a growing need for a systematic and efficient service that encompasses the collection, transportation, disposal, and recycling of specific materials as needed.
Certain treatment, disposal, and recycling processes emit harmful gases and compounds, including mercury and oxides. According to the World Health Organization, healthcare activities generate significant volumes of waste globally, with about 85% classified as non-hazardous and around 15% considered hazardous, requiring proper treatment and disposal through regulated systems to prevent health and environmental risk. These hazardous substances pose the risk of land, air, and water pollution, leading to the dissemination of infectious agents and potential cancer risks. The growth of the industry is consequently influenced by advancements in techniques for the treatment, disposal, and recycling of these materials.
In addition, supportive regulatory policies and increasing investments in hazardous and medical waste treatment infrastructure are expected to accelerate market growth by strengthening waste disposal capabilities and ensuring compliance with stringent environmental standards. For instance, in June 2025, Veolia announced the strategic expansion of its U.S. hazardous waste treatment business through three acquisitions and organic capacity enhancements. As part of this initiative, the company committed more than USD 350 million over three years to expand treatment infrastructure and enhance operational capabilities across North America. The expansion is expected to improve waste collection, treatment, and disposal capacity while enabling healthcare providers to manage the growing volumes of infectious and hazardous medical waste more efficiently. Such investments reflect the rising demand for integrated, compliant, and sustainable medical waste management solutions driven by expanding healthcare services and increasingly stringent waste disposal regulations.
Also, there is a rise in R&D investment and facility expansion by pharmaceutical and biotechnology firms to support the approval and launch of new drugs in the market. High R&D investments and adequate supply and logistics facilities are likely to increase the likelihood of a successful drug/medicine.
However, an anticipated significant transition in the market, moving from larger players to smaller local players, is expected to hinder growth. Developing countries allocate substantial capital for the adoption of advanced technologies aimed at mitigating pollution and other adverse effects on the ecosystem during the treatment and disposal processes. However, these nations lack clear and stringent guidelines and regulations for the management of medical waste, posing a hindrance to market growth.
▪ Treatment
▪ Recycling
▪ Others
▪ Treatment
▪ Recycling
▪ Others
▪ Canada
▪ Germany
▪ France
▪ Italy
▪ Spain
▪ Denmark
▪ Sweden
▪ Norway
▪ China
▪ India
▪ South Korea
▪ Australia
▪ Thailand
▪ Mexico
▪ Argentina
▪ Saudi Arabia
▪ UAE
▪ Kuwait
In addition, the growing incidence of diseases like cancer and other chronic disorders, along with an increasing elderly population and road accidents, is leading to a heightened demand for these advanced medical solutions. Consequently, the widespread availability of advanced medical solutions, combined with a growing patient population, is resulting in a significant volume of waste and byproducts.
The pharmaceutical industry is experiencing swift progress in the adoption of innovative manufacturing techniques for drugs and medical devices. In addition, the market's expansion is evident in the effective supply chain management of inventory, which is crucial to the daily operations of hospitals, clinics, and diagnostic centers. Consequently, this heightened activity contributes to increased generation of medical waste. To manage these by-products and residues, there is a growing need for a systematic and efficient service that encompasses the collection, transportation, disposal, and recycling of specific materials as needed.
Certain treatment, disposal, and recycling processes emit harmful gases and compounds, including mercury and oxides. According to the World Health Organization, healthcare activities generate significant volumes of waste globally, with about 85% classified as non-hazardous and around 15% considered hazardous, requiring proper treatment and disposal through regulated systems to prevent health and environmental risk. These hazardous substances pose the risk of land, air, and water pollution, leading to the dissemination of infectious agents and potential cancer risks. The growth of the industry is consequently influenced by advancements in techniques for the treatment, disposal, and recycling of these materials.
In addition, supportive regulatory policies and increasing investments in hazardous and medical waste treatment infrastructure are expected to accelerate market growth by strengthening waste disposal capabilities and ensuring compliance with stringent environmental standards. For instance, in June 2025, Veolia announced the strategic expansion of its U.S. hazardous waste treatment business through three acquisitions and organic capacity enhancements. As part of this initiative, the company committed more than USD 350 million over three years to expand treatment infrastructure and enhance operational capabilities across North America. The expansion is expected to improve waste collection, treatment, and disposal capacity while enabling healthcare providers to manage the growing volumes of infectious and hazardous medical waste more efficiently. Such investments reflect the rising demand for integrated, compliant, and sustainable medical waste management solutions driven by expanding healthcare services and increasingly stringent waste disposal regulations.
Also, there is a rise in R&D investment and facility expansion by pharmaceutical and biotechnology firms to support the approval and launch of new drugs in the market. High R&D investments and adequate supply and logistics facilities are likely to increase the likelihood of a successful drug/medicine.
However, an anticipated significant transition in the market, moving from larger players to smaller local players, is expected to hinder growth. Developing countries allocate substantial capital for the adoption of advanced technologies aimed at mitigating pollution and other adverse effects on the ecosystem during the treatment and disposal processes. However, these nations lack clear and stringent guidelines and regulations for the management of medical waste, posing a hindrance to market growth.
Global Medical Waste Management Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this report, the analyst has segmented the Medical Waste Management market report based on treatment sites, treatment, and region:Treatment Site Outlook (Revenue, USD Billion, 2021 - 2033)
- Onsite
▪ Treatment
▪ Recycling
▪ Others
- Offsite
▪ Treatment
▪ Recycling
▪ Others
Treatment Outlook (Revenue, USD Billion, 2021 - 2033)
- Incineration
- Autoclaving
- Chemical treatment
- Others
Regional Outlook (Revenue, USD Billion, 2021 - 2033)
- North America
▪ Canada
- Europe
▪ Germany
▪ France
▪ Italy
▪ Spain
▪ Denmark
▪ Sweden
▪ Norway
- Asia Pacific
▪ China
▪ India
▪ South Korea
▪ Australia
▪ Thailand
- Latin America
▪ Mexico
▪ Argentina
- Middle East & Africa
▪ Saudi Arabia
▪ UAE
▪ Kuwait
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Medical Waste Management Market: Executive Summary
Chapter 3. Medical Waste Management Market Variables, Trends, & Scope
Chapter 4. Medical Waste Management: Treatment Site Estimates & Trend Analysis
Chapter 5. Medical Waste Management: Treatment Estimates & Trend Analysis
Chapter 6. Regional Business Analysis
Chapter 7. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- REMONDIS SE & Co. KG
- Republic Services, Inc.
- Sharp Compliance, Inc.
- Stericycle, Inc.
- Suez environment
- Veolia
- Waste Management, Inc.
- Clean Harbors, Inc.
- BioMedical Waste Solutions LLC
- Daniels Sharpsmart, Inc.
